Approving medicines for children with PH – can you help?

Researchers are calling for patient views on approving medicines for children with pulmonary hypertension.

The European Medicine Agency (EMA), along with the US Food and Drug Administration (FDA) and Health Canada, are reviewing the process by which medicines are granted approval for use in children. 

They would like to hear the view of patients with pulmonary hypertension and have produced an online questionnaire. Share your views by clicking here  


emea_strap_url_cmyk_rev_en_std_cent.eps MASTER



Last medically reviewed: May, 2017 • May, 2020